Paragon Genomics
PrivateLast Round
Series A
Sep 12, 2017
Total Funding Raised
$8M
Company Overview
Paragon Genomics is a life science company that develops and commercializes advanced target enrichment and library preparation solutions for Next-Generation Sequencing (NGS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paragon Genomics Comparables
Compare Paragon Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pillar Biosciences | 86% | |
| SeqWell | 85% | |
| Pillar Therapeutics, Inc. | 84% |
Paragon Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 12, 2017 |
Paragon Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heda Ventures | Series A |
| Cloudstone Capital | Series A |
| HEDA Ventures | Series A |
| Cowin Capital | Series A |
| Wisemont Capital | Series A |
Paragon Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Paragon Genomics's valuation, stock price, and market status.
Is Paragon Genomics a public or private company?
Paragon Genomics is a private company.
What is the current stock price of Paragon Genomics?
Paragon Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Paragon Genomics worth (valuation)?
Valuation information for Paragon Genomics is not publicly available.
Can I buy Paragon Genomics stock?
Paragon Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Paragon Genomics's last funding round?
Paragon Genomics's most recent funding round was Series A on September 12, 2017.
Who are the main investors in Paragon Genomics?
Key investors in Paragon Genomics include Heda Ventures, Cloudstone Capital, Wisemont Capital.
Will Paragon Genomics IPO soon?
No public IPO plans have been announced for Paragon Genomics.
How can I track Paragon Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paragon Genomics's secondary market activity and sign up for updates.